Emulate Garners $12,000,000 Series A Funding Round

  • Feed Type
  • Date
    7/29/2014
  • Company Name
    Emulate
  • Mailing Address
    Undisclosed Cambridge, MA 02138 USA
  • Company Description
    Emulate launches to commercialize automated human Organs-on-Chips platform to accelerate drug development, detect toxicities and advance personalized medicine.
  • Website
    http://www.emulatebio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Emulate will use the proceeds from the financing to advance the first commercial applications of its automated Organs-on-Chips platform through co-innovation with corporate and clinical clients, and through internal development programs.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy